UK halts trial of 'useless' hydroxychloroquine in COVID-19 patients

British scientists halted a large trial on Friday that had been exploring the use of the anti-malaria drug hydroxychloroquine in patients with the pandemic disease COVID-19 after initial results showed no evidence of benefit.